Sign In
Buy CAMP
$3.96
-0.230 (-5.49%)
At Close: Jun 15, 2026
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 20'th Feb 2026
CAMBRIDGE, Mass., Feb. 20, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 16'th Jan 2026
CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline
Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
11:45pm, Wednesday, 14'th Jan 2026
Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Canadian GoldCamps Closes Second Tranche of Private Placement
05:00pm, Wednesday, 14'th Jan 2026
Vancouver, January 14, 2026 – TheNewswire - Canadian GoldCamps Corp. (CSE: CAMP) (FSE: A68) (the “ Company ”) is pleased to announce that it has closed the second and final tranche (the “Secon
CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why
01:00pm, Tuesday, 13'th Jan 2026
CAMP4 Therapeutics Corporation (CAMP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
08:00am, Tuesday, 06'th Jan 2026
CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline
Canadian GoldCamps Closes First Tranche of Private Placement and Issues LOI Consideration Shares
07:30am, Friday, 02'nd Jan 2026
Vancouver, January 2, 2026 – Canadian GoldCamps Corp. (CSE: CAMP) (FSE: A68) (the “ Company ”) is pleased to announce that it has closed the first tranche (the “First Tranche”) of its previo
VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Canadian GoldCamps Corp. (CSE: CAMP) (OTC: SMATF) (FSE: A68) (the “Company”) is pleased to announce management and board changes, a n
GSK Deal Is Key Validation For CAMP4's Drug Discovery Platform: Analyst
10:36am, Friday, 19'th Dec 2025
CAMP4 signs ASO collaboration with GSK, securing $17.5 million upfront as analysts reaffirm Outperform and highlight 2026 clinical milestones.
CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
07:10am, Thursday, 18'th Dec 2025
CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or the “Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline o
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
07:00am, Thursday, 18'th Dec 2025
Collaboration to leverage CAMP4's RAP Platform® to accelerate development of novel antisense oligonucleotides (ASOs) for neurodegenerative and renal diseases
CalAmp Earns Caterpillar Supplier Excellence Certification for Second Consecutive Year
02:00pm, Wednesday, 17'th Dec 2025
CalAmp earns Caterpillar Supplier Excellence Certification for second year, highlighting quality, on-time delivery and automotive-grade manufacturing.
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 12'th Dec 2025
CAMBRIDGE, Mass., Dec. 12, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline
CSE Bulletin: Resumption - Canadian GoldCamps Corp. (CAMP)
03:28pm, Tuesday, 09'th Dec 2025
Toronto, Ontario--(Newsfile Corp. - Le 9 décembre/December 2025) - Canadian GoldCamps Corp. (“Canadian GoldCamps”) has announced that, further to its news release dated October 23, 2024, the amen
Canadian GoldCamps Provides Update on Definitive Agreement to Acquire 70% interest in Murphy Lake Property
08:05am, Friday, 05'th Dec 2025
Vancouver, British Columbia and Toronto, Ontario – TheNewswire - December 5, 2025 – Canadian GoldCamps Corp. (“ Canadian GoldCamps ”, or the “ Company ”) (CSE: CAMP) (FSE: A68) (OTC: SMA
